Literature DB >> 1705027

Reconstitution in vitro of RNase H activity by using purified N-terminal and C-terminal domains of human immunodeficiency virus type 1 reverse transcriptase.

Z Hostomsky1, Z Hostomska, G O Hudson, E W Moomaw, B R Nodes.   

Abstract

Two constituent protein domains of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase were expressed separately and purified to homogeneity. The N-terminal domain (p51) behaves as a monomeric protein exhibiting salt-sensitive DNA polymerase activity. The C-terminal domain (p15) on its own has no detectable RNase H activity. However, the combination of both isolated p51 and p15 in vitro leads to reconstitution of RNase H activity on a defined substrate. These results demonstrate that domains of HIV-1 reverse transcriptase are functionally interdependent to a much higher degree than in the case of reverse transcriptase from Moloney murine leukemia virus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1705027      PMCID: PMC50974          DOI: 10.1073/pnas.88.4.1148

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.

Authors:  F di Marzo Veronese; T D Copeland; A L DeVico; R Rahman; S Oroszlan; R C Gallo; M G Sarngadharan
Journal:  Science       Date:  1986-03-14       Impact factor: 47.728

2.  Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants.

Authors:  A Hizi; C McGill; S H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

3.  Isolation of cloned Moloney murine leukemia virus reverse transcriptase lacking ribonuclease H activity.

Authors:  M L Kotewicz; C M Sampson; J M D'Alessio; G F Gerard
Journal:  Nucleic Acids Res       Date:  1988-01-11       Impact factor: 16.971

4.  Functional organization of the murine leukemia virus reverse transcriptase: characterization of a bacterially expressed AKR DNA polymerase deficient in RNase H activity.

Authors:  J G Levin; R J Crouch; K Post; S C Hu; D McKelvin; M Zweig; D L Court; B I Gerwin
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

5.  HIV-1 reverse transcriptase: crystallization and analysis of domain structure by limited proteolysis.

Authors:  D M Lowe; A Aitken; C Bradley; G K Darby; B A Larder; K L Powell; D J Purifoy; M Tisdale; D K Stammers
Journal:  Biochemistry       Date:  1988-12-13       Impact factor: 3.162

6.  Inhibition of RNase H activity and viral replication by single mutations in the 3' region of Moloney murine leukemia virus reverse transcriptase.

Authors:  R Repaske; J W Hartley; M F Kavlick; R R O'Neill; J B Austin
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

7.  Processing protease and reverse transcriptase from human immunodeficiency virus type I polyprotein in Escherichia coli.

Authors:  J Mous; E P Heimer; S F Le Grice
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

8.  Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus.

Authors:  M M Lightfoote; J E Coligan; T M Folks; A S Fauci; M A Martin; S Venkatesan
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

9.  AIDS virus reverse transcriptase defined by high level expression in Escherichia coli.

Authors:  B Larder; D Purifoy; K Powell; G Darby
Journal:  EMBO J       Date:  1987-10       Impact factor: 11.598

10.  Identification and characterization of HIV-specific RNase H by monoclonal antibody.

Authors:  J Hansen; T Schulze; W Mellert; K Moelling
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

View more
  41 in total

1.  Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase.

Authors:  J G Julias; A L Ferris; P L Boyer; S H Hughes
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Reverse transcriptase of human immunodeficiency virus type 1: functionality of subunits of the heterodimer in DNA synthesis.

Authors:  Z Hostomsky; Z Hostomska; T B Fu; J Taylor
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

3.  Defects in Moloney murine leukemia virus replication caused by a reverse transcriptase mutation modeled on the structure of Escherichia coli RNase H.

Authors:  A Telesnitsky; S W Blain; S P Goff
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

4.  Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1.

Authors:  P L Boyer; A L Ferris; S H Hughes
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

5.  Characterization of the double stranded RNA dependent RNase activity associated with recombinant reverse transcriptases.

Authors:  H Ben-Artzi; E Zeelon; S F Le-Grice; M Gorecki; A Panet
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

6.  Characterization of HIV-1 reverse transcriptase with antibodies indicates conformational differences between the RNAse H domains of p 66 and p 15.

Authors:  A M Szilvay; S Nornes; A Kannapiran; B I Haukanes; C Endresen; D E Helland
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

7.  Fusion with an RNA binding domain to confer target RNA specificity to an RNase: design and engineering of Tat-RNase H that specifically recognizes and cleaves HIV-1 RNA in vitro.

Authors:  Y F Melekhovets; S Joshi
Journal:  Nucleic Acids Res       Date:  1996-05-15       Impact factor: 16.971

8.  Adaptive amino acid replacements accompanied by domain fusion in reverse transcriptase.

Authors:  T Shirai; M Go
Journal:  J Mol Evol       Date:  1997       Impact factor: 2.395

9.  Purification and characterization of an active human immunodeficiency virus type 1 RNase H domain.

Authors:  J S Smith; M J Roth
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  Functional organization of repeat addition processivity and DNA synthesis determinants in the human telomerase multimer.

Authors:  Tara J Moriarty; Delphine T Marie-Egyptienne; Chantal Autexier
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.